汉化版MDS-UPDRS与传统UPDRS评测帕金森病的比较分析

doi:10.3969/j.issn.1006-9771.2019.08.010

《中国康复理论与实践》 ›› 2019, Vol. 25 ›› Issue (8): 936-939.doi: 10.3969/j.issn.1006-9771.2019.08.010

汉化版MDS-UPDRS与传统UPDRS评测帕金森病的比较分析

曲艳, 李晓红, 孙亚南, 李亚慧

大连市友谊医院，辽宁大连市 116001

收稿日期:2019-05-22 修回日期:2019-06-16 出版日期:2019-08-25 发布日期:2019-08-16
通讯作者: 李晓红，E-mail: xhlihh@126.com
作者简介:曲艳(1985-)，女，汉族，山东烟台市人，硕士，主治医师，主要研究方向：帕金森病。
基金资助:
大连市医学科学研究项目(No. 1611029)

Evaluation for Parkinson's Disease with Chinese Version of MDS-UPDRS and Original UPDRS

QU Yan, LI Xiao-hong, SUN Ya-nan, LI Ya-hui

Dalian Friendship Hospital, Dalian, Liaoning 116001, China

Received:2019-05-22 Revised:2019-06-16 Published:2019-08-25 Online:2019-08-16
Contact: LI Xiao-hong, E-mail: xhlihh@126.com
Supported by:
Supported by Dalian Medical Science Research Project (No. 1611029)

摘要/Abstract

摘要： 目的研究汉化版国际帕金森和运动障碍协会(MDS)-统一帕金森病评定量表(UPDRS)的信度和效度，及其与传统UPDRS的比较分析。方法 2016年5月至2018年12月，分别对225例帕金森病患者进行两个量表的测评，评价MDS-UPDRS的信度和效度，进一步对两个量表作相关分析。结果 MDS-UPDRS整体Cronbach α系数为0.734。秩相关系数为0.905。因子分析KMO统计量为0.728。Pearson相关分析，两个量表的公因子相关系数为0.969，两个量表的总分相关系数为0.972。且MDS-UPDRS相比UPDRS，增加了许多非运动症状，调整了度量标准从而提高了对疾病早期评估的精确度，增加了大量指导语从而规范测评。结论汉化版MDS-UPDRS具有较好的信度和效度，与传统UPDRS相关性较高，且比UPDRS更适合用于中国帕金森病患者进行临床评定。

关键词: 帕金森病, 汉化版国际运动障碍协会-统一帕金森病评定量表, 统一帕金森病评定量表

Abstract: Objective To evaluate the reliability and validity of Chinese version of International Parkinson and Movement Disorder Society (MDS)-Unified Parkinson's Disease Rating Scale (UPDRS), and then do comparative analysis with original UPDRS. Methods From May, 2016 to December, 2018, 225 patients with Parkinson's disease were respectively evaluated by MDS-UPDRS and UPDRS, and then the reliability and validity of MDS-UPDRS were evaluated. Correlation between two scales was analyzed. Results The Cronbach's coefficient of the total MDS-UPDRS was 0.734. Rank correlation's coefficient was 0.905. For factor analysis, KMO was 0.728. Pearson's correlation analysis showed that the correlation's coefficient of the common factor of the two scales was 0.969, while the correlation's coefficient of the total score of the two scales was 0.972. Compared with UPDRS, MDS-UPDRS added a number of non-motor symptoms, which adjusted the standard of measurement and increased the accuracy degree of evaluation at early stage of disease. Besides, MDS-UPDRS added a lot of instructions to evaluate the standards to make the evaluation normatively. Conclusion Chinese version of MDS-UPDRS has high reliability and validity, and highly correlate with the original UPDRS. It is more suitable for Chinese patients with Parkinson's disease in clinical evaluation than UPDRS.

Key words: Parkinson's disease, Chinese version of International Parkinson and Movement Disorder Society-Unified Parkinson's Disease Rating Scale, Unified Parkinson's Disease Rating Scale

中图分类号:

R742.5

曲艳, 李晓红, 孙亚南, 李亚慧. 汉化版MDS-UPDRS与传统UPDRS评测帕金森病的比较分析[J]. 《中国康复理论与实践》, 2019, 25(8): 936-939.

QU Yan, LI Xiao-hong, SUN Ya-nan, LI Ya-hui. Evaluation for Parkinson's Disease with Chinese Version of MDS-UPDRS and Original UPDRS[J]. 《Chinese Journal of Rehabilitation Theory and Practice》, 2019, 25(8): 936-939.

参考文献

1 Martinez-MartinP, Rodriguez-BlazquezC, Alvarez-SanchezM, et al. Expanded and independent validation of the Movement Disorder Society-Unified Parkinson’s Disease Rating Scale (MDS-UPDRS) [J]. J Neurol, 2013, 260(1): 228-236.
2 AntoniniA, AbbruzzeseG, Ferini-StrambiL, et al. Validation of the Italian version of the Movement Disorder Society-Unified Parkinson’s Disease Rating Scale [J]. Neurol Sci, 2013, 34(5): 683-687.
3 KashiharaK, KondoT, MizunoY, et al. Official Japanese Version of the Movement Disorder Society-Unified Parkinson’s Disease Rating Scale: validation against the original English version [J]. Mov Disord Clin Pract, 2014, 1(3): 200-212.
4 AkbostanciM C, BayramE, YilmazV, et al. Turkish Standardization of Movement Disorders Society Unified Parkinson's Disease Rating Scale and Unified Dyskinesia Rating Scale [J]. Mov Disord Clin Pract, 2017, 5(1): 54-59.
5 ZitserJ, PeretzC, Ber DavidA, et al. Validation of the Hebrew version of the Movement Disorder Society-Unified Parkinson's Disease Rating Scale [J]. Parkinsonism Relat Disord, 2017, 45: 7-12.
6 中华医学会神经病学分会帕金森病及运动障碍学组,中国医师协会神经内科医师分会帕金森病及运动障碍专业. 中国帕金森病的诊断标准(2016版)[J]. 中华神经科杂志, 2016, 49(4): 268-271.
7 GoetzC G, PoeweW, RascolO, et al. The Unified Parkinson's Disease Rating Scale (UPDRS): status and recommendations [J]. Mov Disord, 2003, 18(7): 738-750.
8 GoetzC G, TilleyB C, ShaftmanS R, et al. Movement Disorder Society-Sponsored Revision of the Unified Parkinson’s Disease Rating Scale (MDS-UPDRS): scale presentation and clinimetric testing results [J]. Mov Disord, 2008, 23(15): 2129-2170.
9 LangA E, EberlyS, GoetzC G, et al. Movement disorder society unified Parkinson disease rating scale experiences in daily living: longitudinal changes and correlation with other assessments [J]. Mov Disord, 2013, 28(14): 1980-1986.
10 Rodriguez-BlazquezC, Rojo-AbuinJ M, Alvarez-SanchezM, et al. The MDS-UPDRS Part II (motor experiences of daily living) resulted useful for assessment of disability in Parkinson's disease [J]. Parkinsonism Relat Disord, 2013, 19(10): 889-893.
11 RacitiL, NicolettiA, MostileG, et al. Accuracy of MDS-UPDRS section IV for detecting motor fluctuations in Parkinson's disease [J]. Neurol Sci, 2019, 40(6): 1271-1273.
12 Martinez-MartinP, Rodriguez-BlazguezC, AlvarezMario, et al. Parkinson's disease severity levels and MDS-Unified Parkinson's Disease Rating Scale [J]. Parkinsonism Relat Disord, 2015, 21(1): 50-54.
13 RegnaultA, BoroojerdiB, MeunierJ, et al. Does the MDS-UPDRS provide the precision to assess progression in early Parkinson's disease? Learnings from the Parkinson's progression marker initiative cohort [J]. J Neurol, 2019, 266(8): 1927-1936.

[1]	王靖萱, 吕迪阳, 方伯言. 帕金森病步态异常非药物康复循证研究：基于ClinicalTrials.gov数据库分析[J]. 《中国康复理论与实践》, 2023, 29(7): 816-821.
[2]	吴佳玉, 孟德涛, 梁潇潇. 体力活动水平对帕金森病发病风险的影响：基于CHARLS数据的横断面分析[J]. 《中国康复理论与实践》, 2023, 29(10): 1135-1139.
[3]	石曼欣妤,孟德涛,方伯言. 帕金森病康复研究进展的可视化分析[J]. 《中国康复理论与实践》, 2022, 28(9): 1060-1064.
[4]	王洁萍,彭娟,张斐雪,樊必双,胥方元. 肢体协调训练对早期原发性帕金森病患者肺功能的效果[J]. 《中国康复理论与实践》, 2022, 28(8): 966-971.
[5]	谭茗丹,冯锭瑶,陈曦,刘汉军,李咏雪. 中文版构音障碍影响程度量表对帕金森病患者的信度和效度[J]. 《中国康复理论与实践》, 2022, 28(6): 696-703.
[6]	席晓明,毕鸿雁. 腹部扭转运动对帕金森病患者抑郁、便秘、运动症状和生活质量的效果[J]. 《中国康复理论与实践》, 2022, 28(2): 220-226.
[7]	刘阳,张孝权,王恒,齐莉萍. 虚拟现实技术对帕金森病患者综合平衡能力改善的Meta分析[J]. 《中国康复理论与实践》, 2021, 27(9): 1048-1058.
[8]	曹海豪,孙文玉,席晓明,王丽敏,毕鸿雁. 五禽戏对帕金森病患者平衡功能、步行能力及生活质量的效果[J]. 《中国康复理论与实践》, 2021, 27(9): 1087-1092.
[9]	肖琳娜,李晓红. 帕金森病冲动控制障碍的Scoping综述[J]. 《中国康复理论与实践》, 2021, 27(7): 774-779.
[10]	马惠姿,房进平,冯涛,蒋莹. 帕金森病患者不同程度抑郁在汉密尔顿抑郁量表的结构差异[J]. 《中国康复理论与实践》, 2021, 27(7): 829-833.
[11]	柳欣,尹志科,冯涛,邓永梅,赵越颖,董可,王春雪,马惠姿. 帕金森病并发淡漠的危险因素研究[J]. 《中国康复理论与实践》, 2021, 27(6): 719-723.
[12]	厉坤鹏,周宗磊,张梓楠,施伯翰,陈浩,罗云,朱燕. 呼吸训练对帕金森病患者肺功能和运动功能的效果[J]. 《中国康复理论与实践》, 2021, 27(3): 320-324.
[13]	蒋莹,房进平,冯涛,马惠姿. 帕金森病患者不同焦虑程度在汉密尔顿焦虑量表的结构差异[J]. 《中国康复理论与实践》, 2021, 27(3): 325-328.
[14]	王翔宇, 董青, 董双双, 蔡增林. 八段锦联合平衡训练改善帕金森病运动和非运动症状的效果[J]. 《中国康复理论与实践》, 2021, 27(1): 111-116.
[15]	孙文玉,毕鸿雁. 导引术对帕金森病患者运动、平衡和生活质量的影响[J]. 《中国康复理论与实践》, 2020, 26(7): 836-841.

汉化版MDS-UPDRS与传统UPDRS评测帕金森病的比较分析

Evaluation for Parkinson's Disease with Chinese Version of MDS-UPDRS and Original UPDRS

PDF (PC)

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 15

Metrics

本文评价

推荐阅读 0